| [1] |
王中一, 徐彧, 张海燕, 等. 以T淋巴母细胞淋巴瘤为首发表现的慢性髓系白血病1例报道[J]. 解放军医学院学报, 2019, 40(1):88-90.
|
| [2] |
王慧睿, 郭淑利, 李波, 等. 以急变期为首发的慢性粒细胞白血病三例临床及实验室特征分析[J]. 白血病·淋巴瘤, 2018, 27(5):280-284.
|
| [3] |
ABDULMAWJOOD B, COSTA B, ROMA-RODRIGUES C, et al. Genetic biomarkers in chronic myeloid leukemia:what have we learned so far?[J]. Int J Mol Sci, 2021, 22(22):12516.
|
| [4] |
UCHIDA T, DOKI N, KISHIDA Y, et al. Tyrosine kinase inhibitor maintenance therapy following allogenic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia[J]. Rinsho Ketsueki, 2020, 61(1):11-19.
|
| [5] |
CRUZ S S D, SEABRA A D, MACAMBIRA L H R, et al. Chronic myelogenous leukemia with double philadelphia chromosome and coexpression of p210 and p190 fusion transcripts[J]. Genes(Basel), 2022, 13(4):580.
|
| [6] |
HUGHES T P, MAURO M J, CORTES J E, et al. Asciminib in chronic myeloid leukemia after ABL kinase inhibitor failure[J]. N Engl J Med, 2019, 381(24):2315-2326.
|
| [7] |
KHOURY J D, SOLARY E, ABLA O, et al. The 5th edition of the World Health Organization Classification of haematolymphoid tumours:myeloid and histiocytic/dendritic neoplasms[J]. Leukemia, 2022, 36(7):1703-1719.
|
| [8] |
张羽, 张阳, 王芳, 等. 急性混合细胞白血病患者FLT3基因突变特征及酪氨酸激酶抑制剂的临床疗效[J]. 白血病·淋巴瘤, 2020, 29(1):37-40.
|
| [9] |
谢守军, 王娜, 彭兴荣, 等. 以Ph+急性杂合性细胞白血病为首发表现的慢粒白血病急性变1例[J]. 临床检验杂志, 2008, 26(4):320.
|
| [10] |
张旭艳, 涂传清, 黎建云, 等. 急性白血病起始的慢粒急变4例报道并文献复习[J]. 标记免疫分析与临床, 2019, 26(7):1256-1260.
|
)
